Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19403902 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Telaprevir;   Drug: Ribavirin;   Drug: Pegylated Interferon Alfa 2a;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.